Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Effects of tumor-specific CAP1 expression and body constitution on clinical outcomes in patients with early breast cancer

Fig. 2

Predicted breast cancer-specific survival (BCSS) and overall survival (OS) comparing three groups of CAP1 cytoplasmic intensity. BCSS and OS among all patients and stratified by ER status. Patients at risk, number of events (NoE), LogRank trend test, and adjusted hazard ratios (HRs) with 95% CI comparing low CAP1 expression to high CAP1 expression are shown. HR adjusted for age at diagnosis (continuous), tumor size (> 20 mm, yes/no), and any axillary lymph node involvement (yes/no)

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us